Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
Clinical trial NCT06077773 · TERMINATED
Trial details
- NCT number
- NCT06077773
- Sponsor
- Escient Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2024-12-18
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.